Advik Laboratories Ltd — Important, 02-09-2026: Company Update

MPS Pharmaa Limited's board has announced key decisions from its recent meeting. The board approved the 32nd Annual General Meeting (AGM) and its documentation for the financial year 2025-2026. The company set book closure and e-voting periods, appointing NSDL and M/s. Kundan Agrawal & Associates for the voting process. For shareholder approval at the AGM, the board put forward the appointment of Ms. Anchal Goyal as an Independent Director for five years and the re-appointment of M/s. Nemani Garg Agarwal & Co. as Statutory Auditors for a similar term. The board also proposed authorization under Section 185 of the Companies Act, 2013. These decisions impact company governance and financial oversight.